Annual report
4109.TEDINET S100R7UK
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100RQK5 (2023-08-23).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥35.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥37.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥32.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥33.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.5bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥4.6bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.3bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.0bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.8bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.4bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥6.8bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.0bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.4bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥5.0bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥55.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥56.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥52.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥53.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥55.5bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.3bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥13.9bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥43.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥42.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥36.8bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥34.7bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥33.9bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.7bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.3bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥12.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥3.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥94m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥715m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥321m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥186.03 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥422.97 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥230.7 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥149 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥182.06 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,568.67 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,369.93 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,826.78 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,635.5 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,541.77 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 77.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.4% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.0% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.2% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 727 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 760 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 813 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 830 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 815 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥20.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥23.3bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥21.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥21.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥28.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.5bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥4.3bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥3.6bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.1bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.7bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.9bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥5.8bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥4.3bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥3.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥38.5bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥40.1bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥38.7bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥38.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥39.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.8bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥9.0bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥30.7bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥31.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥28.3bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥26.2bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥24.7bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥9.0bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥10.7bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥146.97 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥337.46 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥230.31 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥157.71 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.8 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥60 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥47 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,552.61 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,484.99 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,205.61 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,025.05 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,914.54 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.5% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.8% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 13,213,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 13,213,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 13,213,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 13,213,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 13,213,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 284 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 286 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 297 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 309 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 303 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 81
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 13 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥399m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥170m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥228m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥290m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥30m |
| High Purity Chemicalreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥4.9bn |
| High Purity Chemicalreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| High Purity Chemicalreportable segment | employees | at 2023-03-31 | 399 pure |
| High Purity Chemicalreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥30.7bn |
| High Purity Chemicalreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥30.7bn |
| High Purity Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥0 |
| High Purity Chemicalreportable segment | segment assets | at 2023-03-31 | ¥45.9bn |
| High Purity Chemicalreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥3.0bn |
| Transportationreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥539m |
| Transportationreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥486m |
| Transportationreportable segment | employees | at 2023-03-31 | 315 pure |
| Transportationreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥7.8bn |
| Transportationreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.5bn |
| Transportationreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥3.3bn |
| Transportationreportable segment | segment assets | at 2023-03-31 | ¥9.6bn |
| Transportationreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥533m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥5.4bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥2.6bn |
| —segment total | employees | at 2023-03-31 | 714 pure |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥38.5bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥35.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥3.3bn |
| —segment total | segment assets | at 2023-03-31 | ¥55.5bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥38.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥35.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥55.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥404m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥189m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥215m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥268m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥20m |
| High Purity Chemicalreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| High Purity Chemicalreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2.2bn |
| High Purity Chemicalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥32.6bn |
| High Purity Chemicalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥32.3bn |
| High Purity Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥251m |
| High Purity Chemicalreportable segment | segment assets | at 2022-03-31 | ¥46.6bn |
| High Purity Chemicalreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| Medicalreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥46m |
| Medicalreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥28m |
| Medicalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥100m |
| Medicalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥100m |
| Medicalreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥729m |
| Transportationreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥512m |
| Transportationreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥504m |
| Transportationreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥7.8bn |
| Transportationreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| Transportationreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3.1bn |
| Transportationreportable segment | segment assets | at 2022-03-31 | ¥10.0bn |
| Transportationreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥764m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥2.6bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥2.7bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥40.5bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥37.1bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3.4bn |
| —segment total | segment assets | at 2022-03-31 | ¥56.6bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥40.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥37.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥56.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| High Purity Chemicalreportable segment | employees | at 2023-03-31 | 284 pure |
| —segment total | employees | at 2023-03-31 | 284 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,675
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for directors bonuses sga | CurrentYearDuration | 47000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | 0 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | -3000000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 27000000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 22000000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 6000000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 3000000 | JPY |
| Provision for share based remuneration sga | Prior1YearDuration | 26000000 | JPY |
| Provision for share based remuneration sga | CurrentYearDuration | 26000000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 744000000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 660000000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 744000000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 660000000 | JPY |
| Write downs of inventories | Prior1YearDuration | 23000000 | JPY |
| Write downs of inventories | CurrentYearDuration | 9000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00805-000HighPurityChemicalReportableSegmentsMember | 32330000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00805-000TransportationReportableSegmentsMember | 4676000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00805-000MedicalReportableSegmentsMember | 100000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 37107000000 | JPY |
| Revenues from external customers | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 189000000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 37296000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00805-000HighPurityChemicalReportableSegmentsMember | 251000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00805-000TransportationReportableSegmentsMember | 3145000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00805-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | 3396000000 | JPY |
| Transactions with other segments | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 215000000 | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 3611000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00805-000HighPurityChemicalReportableSegmentsMember | 32581000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00805-000TransportationReportableSegmentsMember | 7822000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00805-000MedicalReportableSegmentsMember | 100000000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 40503000000 | JPY |
| Net sales | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 404000000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 40908000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E00805-000HighPurityChemicalReportableSegmentsMember | 4776000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E00805-000TransportationReportableSegmentsMember | 764000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E00805-000MedicalReportableSegmentsMember | -729000000 | JPY |
| Operating income | Prior1YearDuration_ReportableSegmentsMember | 4811000000 | JPY |
| Operating income | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 20000000 | JPY |
| Operating income | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 4832000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E00805-000HighPurityChemicalReportableSegmentsMember | 46595000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E00805-000TransportationReportableSegmentsMember | 9992000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E00805-000MedicalReportableSegmentsMember | － | JPY |
| Assets | Prior1YearInstant_ReportableSegmentsMember | 56588000000 | JPY |
| Assets | Prior1YearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 268000000 | JPY |
| Assets | Prior1YearInstant_TotalOfReportableSegmentsAndOthersMember | 56856000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E00805-000HighPurityChemicalReportableSegmentsMember | 2179000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E00805-000TransportationReportableSegmentsMember | 504000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E00805-000MedicalReportableSegmentsMember | 28000000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReportableSegmentsMember | 2712000000 | JPY |
| Depreciation segment information | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 0 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |